National Cancer Institute, Acquisition Management Branch, TBS, 6120 Executive Blvd, EPS/Rm 603 Bethesda, MD 20892-7220

R -- DELIVERY OF FENRETINIDE CAPSULES FOR CLINICAL TRIALS POC Odessa S. Henderson, Contract Specialist, 301-435-3821 E-MAIL: oh4o@nih.gov, oh4o@nih.gov. The Cancer Therapy Evaluation Program intends on negotiating with R. W. Johnson Pharmaceutical Research Institute for the procurement of 2,000,000 capsules of fenretinide under contract N02-CM-97032 entitled "Delivery of Fenretinide Capsules for Clinical Trials." This contract provides for the procurement of fenretinide capsules to be used in clinical trials under a DCTD Investigational New Drug Application on file with the FDA. Authority: 41 U.S.C. 253(c)(1), as set forth in FAR 6.302-1 and FAR 6.302-2. See numbered Note 22. No collect calls will be accepted. Posted 07/16/99 (W-SN355488). (0197)

Loren Data Corp. http://www.ld.com (SYN# 0080 19990720\R-0013.SOL)